Author:
Chouhan Surbhi,Singh Snahlata,Athavale Dipti,Ramteke Pranay,Vanuopadath Muralidharan,Nair Bipin G,Nair Sudarslal Sadasivan,Bhat Manoj Kumar
Funder
Intramural grant from National Centre for Cell Science funded by Department of Biotechnology, Government of India and internal funding from Amrita Vishwa Vidyapeetham
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference76 articles.
1. Abou-Alfa GK, Huitzil-Melendez FD, O’Reilly EM and Saltz LB 2008 Current management of advanced hepatocellular carcinoma. Gastrointest. Cancer Res 2 64–70
2. Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, De Greve J, Douillard JY, Lathia C Schwartz B Taylor I, Moscovici M and Saltz LB 2006 Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J. Clin. Oncol. 24 4293–300
3. Amin ML 2013 P-glycoprotein Inhibition for Optimal Drug Delivery, Drug Target Insights. 7 27–34
4. Antunes F, Pereira GJ, Jasiulionis MG, Bincoletto C and Smaili SS 2018 Nutritional shortage augments cisplatin-effects on murine melanoma cells. Chem. Biol. Interact. 281 89–97
5. Aung PP, Oue N, Mitani Y, Nakayama H, Yoshida K, Noguchi T, Bosserhoff AK and Yasui W 2006 Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25 2546–2557
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献